ICH HARMONISED GUIDELINE. ASSESSMENT AND CONTROL OF DNA REACTIVE (MUTAGENIC) IMPURITIES IN. PHARMACEUTICALS TO LIMIT POTENTIAL CARCINOGENIC RISK. M7(R1).
確定! 回上一頁